| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.31B | 10.13B | 12.49B | 8.70B | 6.83B | 6.80B |
| Gross Profit | 3.67B | 3.86B | 1.93B | 1.74B | 2.10B | 1.82B |
| EBITDA | 3.18B | 3.23B | 189.10M | 4.32B | 3.30B | 1.33B |
| Net Income | 885.70M | 1.19B | -158.00M | 3.03B | 2.28B | 167.90M |
Balance Sheet | ||||||
| Total Assets | 30.85B | 30.36B | 27.14B | 25.76B | 21.59B | 21.03B |
| Cash, Cash Equivalents and Short-Term Investments | 433.30M | 1.09B | 1.21B | 1.13B | 1.60B | 421.00M |
| Total Debt | 10.47B | 10.60B | 10.94B | 10.19B | 10.88B | 11.34B |
| Total Liabilities | 17.23B | 17.67B | 17.91B | 17.64B | 16.38B | 17.28B |
| Stockholders Equity | 12.92B | 12.06B | 8.58B | 8.08B | 5.21B | 3.75B |
Cash Flow | ||||||
| Free Cash Flow | -870.70M | -654.20M | -360.90M | 121.40M | 593.30M | 42.80M |
| Operating Cash Flow | 2.64B | 2.48B | 1.46B | 1.58B | 1.77B | 1.25B |
| Investing Cash Flow | -4.01B | -3.32B | -2.96B | -744.90M | 443.70M | -1.01B |
| Financing Cash Flow | 906.10M | 896.20M | 1.35B | -1.38B | -778.70M | -603.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £64.38B | 21.31 | 7.66% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £32.26B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
69 Neutral | £2.98B | 0.40 | 3.94% | 2.78% | -19.04% | -34.52% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £1.04B | 21.07 | 27.40% | 7.01% | 1.71% | -12.49% | |
59 Neutral | £9.60B | -112.68 | 1.68% | 2.86% | -4.82% | -123.58% | |
58 Neutral | £20.24M | -1.05 | -68.06% | ― | -60.76% | -230.39% |